You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Duodenitis

Showing 1 - 25 of 494
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Eosinophilic Gastritis, Eosinophilic Duodenitis, Eosinophilic Gastrointestinal Disease Trial (Dupilumab Dose 1, Dupilumab Dose

Not yet recruiting
  • Eosinophilic Gastritis
  • +2 more
  • Dupilumab Dose 1
  • +2 more
  • (no location specified)
Apr 14, 2023

IBD, Crohn Disease, Crohn Colitis Trial in Boston (Personalized Risk Estimation for Crohn's Disease (PRE-CD) tool, Standard

Not yet recruiting
  • Inflammatory Bowel Diseases
  • +7 more
  • Personalized Risk Estimation for Crohn's Disease (PRE-CD) tool
  • Standard Crohn's Disease Education
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 11, 2022

Eosinophilic Duodenitis, Eosinophilic Gastroenteritis Trial in United States (AK002, Placebo)

Active, not recruiting
  • Eosinophilic Duodenitis
  • Eosinophilic Gastroenteritis
  • Birmingham, Alabama
  • +38 more
Dec 16, 2021

Crohn Disease, Crohn Colitis, Crohn's Ileocolitis Trial in Ventura (No intervention)

Recruiting
  • Crohn Disease
  • +13 more
  • No intervention
  • Ventura, California
    ProgenaBiome
Sep 2, 2021

Eosinophilic Gastritis, Eosinophilic Gastroenteritis, Eosinophilic Duodenitis Trial in United States (AK002)

Active, not recruiting
  • Eosinophilic Gastritis
  • +2 more
  • Phoenix, Arizona
  • +16 more
Jun 21, 2021

Eosinophilic Gastritis, Eosinophilic Duodenitis Trial in United States (AK002, Placebo)

Recruiting
  • Eosinophilic Gastritis
  • Eosinophilic Duodenitis
  • Birmingham, Alabama
  • +73 more
Dec 9, 2021

Eosinophilic Gastritis, Eosinophilic Duodenitis Trial in United States (lirentelimab (AK002), Placebo)

Active, not recruiting
  • Eosinophilic Gastritis
  • Eosinophilic Duodenitis
  • lirentelimab (AK002)
  • Placebo
  • Birmingham, Alabama
  • +59 more
Jul 28, 2021

Eosinophilic Gastritis, Eosinophilic Duodenitis Trial in United States (lirentelimab)

Enrolling by invitation
  • Eosinophilic Gastritis
  • Eosinophilic Duodenitis
  • Gilbert, Arizona
  • +24 more
Jan 6, 2021

Nivolumab, Ipilimumab, and Chemotherapy in Non-small Cell Lung

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • Athens, Greece
      Local Institution - 0001
    Oct 26, 2022

    Small Intestine Disease Trial (Double balloon enteroscopy)

    Not yet recruiting
    • Small Intestine Disease
    • Double balloon enteroscopy
    • (no location specified)
    Jul 20, 2022

    Bariatric Surgery Candidate, Perioperative Complication, Nausea Trial in Tehran (Metoclopramide, Ondansetron, Metoclopramide and

    Completed
    • Bariatric Surgery Candidate
    • +4 more
    • Tehran, Iran, Islamic Republic of
      Loghman Hakim Hospital
    Oct 21, 2021

    Potential Adverse Outcomes in Routine Clinical Practice

    Completed
    • Venous Thrombosis
    • +3 more
    • Rivaroxaban (Xarelto, Bay59-7939)
    • Standard of care
    • Multiple Locations, Germany
      (unnamed)
    Oct 21, 2021

    Potential Adverse Outcomes in Routine Clinical Pratice

    Completed
    • Venous Thrombosis
    • +3 more
    • Rivaroxoban (Xarelto, Bay59-7939)
    • Standard of care
    • Multiple Locations, Netherlands
      (unnamed)
    Sep 22, 2021

    Potential Adverse Outcomes in Routine Clinical Pratice (UK)

    Completed
    • Venous Thrombosis
    • +3 more
    • Rivaroxaban (Xarelto, Bay59-7939)
    • +2 more
    • Multiple Locations, United Kingdom
      (unnamed)
    Sep 22, 2021

    Non Small Cell Lung Cancer Metastatic Trial in Worldwide (TG4010, Chemotherapy, Nivolumab)

    Completed
    Has Results
    • Non Small Cell Lung Cancer Metastatic
    • TG4010
    • +2 more
    • Charlotte, North Carolina
    • +8 more
    Dec 22, 2021

    Advanced Solid Malignancies Trial in Worldwide (MEDI4736 (Durvalumab), MEDI4736 (Durvalumab) + Tremelimumab)

    Active, not recruiting
    Has Results
    • Advanced Solid Malignancies
    • MEDI4736 (Durvalumab)
    • MEDI4736 (Durvalumab) + Tremelimumab
    • Santa Rosa, California
    • +78 more
    Aug 18, 2022

    Healthy Volunteers Trial in Yokohama, Minato-ku, Shinjuku-ku (Celecoxib, Loxoprofen, Placebo)

    Completed
    Has Results
    • Healthy Volunteers
    • Yokohama, Kanagawa, Japan
    • +2 more
    Jan 29, 2021

    GIST Trial in Worldwide (avapritinib, regorafenib)

    Completed
    Has Results
    • GIST
    • Phoenix, Arizona
    • +113 more
    Sep 9, 2022

    Various Advanced Cancer Trial in Worldwide (Nivolumab)

    Completed
    Has Results
    • Various Advanced Cancer
    • Phoenix, Arizona
    • +66 more
    Mar 17, 2022

    COPD (COPD) Trial in Easley (TD-4208, Tiotropium)

    Completed
    Has Results
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Easley, South Carolina
      Palmetto Medical Research Associates L.L.C
    Feb 22, 2022

    Epilepsy, Partial-onset Seizures Trial in China, Japan (Lacosamide)

    Completed
    Has Results
    • Epilepsy
    • Partial-onset Seizures
    • Beijing, China
    • +66 more
    Aug 16, 2021

    Diastolic Heart Failure Trial in Canada, United States (Sitaxsentan sodium, Placebo)

    Completed
    Has Results
    • Diastolic Heart Failure
    • Sitexsentin sodium
    • Placebo
    • Birmingham, Alabama
    • +51 more
    Dec 8, 2022

    Advanced Hepatocellular Carcinoma Trial in Worldwide (Enzalutamide, Placebo)

    Completed
    Has Results
    • Advanced Hepatocellular Carcinoma
    • San Francisco, California
    • +37 more
    Feb 18, 2022

    Non-Small-Cell Lung Carcinoma Trial (biological, drug, dietary supplement)

    Active, not recruiting
    Has Results
    • Non-Small-Cell Lung Carcinoma
    • Pembrolizumab 200 mg
    • +7 more
    • (no location specified)
    Aug 16, 2022

    Cystic Fibrosis Trial in Worldwide (VX-561, IVA, Placebo)

    Completed
    Has Results
    • Cystic Fibrosis
    • Birmingham, Alabama
    • +47 more
    Dec 31, 2021